Kyung Bo Kim discovered compounds that improved cognitive function regardless of amyloid plaque buildup — an encouraging sign ...

Fact checked by Nick Blackmer Zunveyl (benzgalantamine)—a better-tolerated version of the Alzheimer’s drug Razadyne ...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the ...

The gas xenon, like the other noble, or inert, gases, is known for doing very little. The class of elements, because of its ...

A new study has identified polyphosphate as a likely "mystery density" within fibrils associated with Alzheimer's and other ...

A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...

Cutting-edge fluorescent cholesterol probes now enable scientists to visualize cholesterol movement and distribution in live cells with unprecedented detail. By combining computer simulations with ...

The compound, named VU319, is the first end-to-end drug ... Study Supports New Blood-Based Biomarker to Detect Early Brain Changes Leading to Cognitive Impairment and Dementia Dec. 18, 2024 — To ...

Quality time takes on a whole new meaning after an Alzheimer’s diagnosis. “We just finished a two-week European River cruise, ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...

New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...